Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 489

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

Clinical Significance of Four Molecular Subtypes of Gastric Cancer Identified by The Cancer Genome Atlas Project

Open access
Sohn, Bo Hwa, Hwang, Jun-Eul, Jang, Hee-Jin, Lee, Hyun-Sung, Oh, Sang Cheul, Shim, Jae-Jun, Lee, Keun-Wook, Kim, Eui Hyun, Yim, Sun Young, Lee, Sang Ho, Cheong, Jae-Ho, Jeong, Woojin, Cho, Jae Yong, Kim, Joohee, Chae, Jungsoo, Lee, Jeeyun, Kang, Won Ki, Kim, Sung, Noh, Sung Hoon, Ajani, Jaffer A., Lee, Ju-Seog·2017·Clinical Cancer Research

Abstract

Purpose: The Cancer Genome Atlas (TCGA) project recently uncovered four molecular subtypes of gastric cancer: Epstein–Barr virus (EBV), microsatellite instability (MSI), genomically stable (GS), and chromosomal instability (CIN). However, their clinical significances are currently unknown. We aimed to investigate the relationship between subtypes and prognosis of patients with gastric cancer. Experimental Design: Gene expression data from a TCGA cohort (n = 262) were used to develop a subtype prediction model, and the association of each subtype with survival and benefit from adjuvant chemotherapy was tested in 2 other cohorts (n = 267 and 432). An integrated risk assessment model (TCGA risk score) was also developed. Results: EBV subtype was associated with the best prognosis, and GS subtype was associated with the worst prognosis. Patients with MSI and CIN subtypes had poorer overall survival than those with EBV subtype but better overall survival than those with GS subtype (P = 0.004 and 0.03 in two cohorts, respectively). In multivariate Cox regression analyses, TCGA risk score was an independent prognostic factor [HR, 1.5; 95% confidence interval (CI), 1.2–1.9; P = 0.001]. Patients with the CIN subtype experienced the greatest benefit from adjuvant chemotherapy (HR, 0.39; 95% CI, 0.16–0.94; P = 0.03) and those with the GS subtype had the least benefit from adjuvant chemotherapy (HR, 0.83; 95% CI, 0.36–1.89; P = 0.65). Conclusions: Our prediction model successfully stratified patients by survival and adjuvant chemotherapy outcomes. Further development of the prediction model is warranted. Clin Cancer Res; 23(15); 4441–9. ©2017 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/1078-0432.ccr-16-2211

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 40 references

Cited by

See all 489

Metadata

Authors
Sohn, B. H., Hwang, J.-E., Jang, H.-J., Lee, H.-S., Oh, S. C., Shim, J.-J., Lee, K.-W., Kim, E. H., Yim, S. Y., Lee, S. H., Cheong, J.-H., Jeong, W., Cho, J. Y., Kim, J., Chae, J., Lee, J., Kang, W. K., Kim, S., Noh, S. H., Ajani, J. A., & Lee, J.-S.
Venue
Clinical Cancer Research
Published
2017-08-01
Volume
23
Issue
15
Pages
4441-4449
ISSN
  • 1078-0432 (ISSN-L)
  • 1557-3265
OpenAlex
W2737578400
Cited by
489
References
40
FWCI
27.54
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Clinical Significance of Four Molecular Subtypes of Gastric Cancer Identified by The Cancer Genome Atlas Project. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-16-2211
The paper
Sohn, B. H., Hwang, J.-E., Jang, H.-J., Lee, H.-S., Oh, S. C., Shim, J.-J., Lee, K.-W., Kim, E. H., Yim, S. Y., Lee, S. H., Cheong, J.-H., Jeong, W., Cho, J. Y., Kim, J., Chae, J., Lee, J., Kang, W. K., Kim, S., Noh, S. H., . . . Lee, J.-S. (2017). Clinical Significance of Four Molecular Subtypes of Gastric Cancer Identified by The Cancer Genome Atlas Project. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-16-2211

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.